Who
Robert T. McNally
Director
Company insider
Files Form 4 as: President/CEO, GeoVax Labs.
In numbers
- Trades disclosed
- 37
- Buys
- 9
- Sells
- 0
- Bought
- $320K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 14 Mar 2007
- Last trade
- 17 Jun 2026
- Last filed
- 22 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Jun 2026filed 22 Jun 2026 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,000 at $0.00 | filing |
| 17 Jun 2026filed 22 Jun 2026 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,000 at $0.00 | filing |
| 5 Jun 2025filed 6 Jun 2025 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 12 Aug 2024filed 14 Aug 2024 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,050 at $0.00 | filing |
| 1 Aug 2023filed 14 Aug 2023 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 7 Dec 2021filed 8 Dec 2021 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 11 Aug 2021filed 11 Aug 2021 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 29 Sep 2020filed 29 Sep 2020 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code P | —53,925 at $0.00 | filing |
| 29 Sep 2020filed 29 Sep 2020 | GOVX GeoVax LabsBiotechnology | SEC FORM 4 Bought | $270K53,925 at $5.00 | filing |
| 17 Dec 2018filed 19 Dec 2018 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —650,000 at $0.00 | filing |
| 20 Dec 2017filed 22 Dec 2017 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —750,000 at $0.00 | filing |
| 13 Dec 2016filed 15 Dec 2016 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —462,500 at $0.00 | filing |
| 11 Dec 2015filed 14 Dec 2015 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 9 Dec 2014filed 11 Dec 2014 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 18 Dec 2013filed 20 Dec 2013 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 11 Dec 2012filed 3 Jan 2013 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 30 Dec 2011filed 4 Jan 2012 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code P | —44,775 at $0.00 | filing |
| 30 Dec 2011filed 4 Jan 2012 | GOVX GeoVax LabsBiotechnology | SEC FORM 4 Bought | $20K29,850 at $0.67 | filing |
| 30 Dec 2011filed 4 Jan 2012 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 10 Dec 2010filed 14 Dec 2010 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
News
Lisata Therapeutics (NASDAQ:LSTA) & GeoVax Labs (NASDAQ:GOVX) Head to Head ContrastGOVX · dailypolitical.com · 8 Oct 2026
0 headlines in the last 90 days name Robert T. McNally; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.